Skip to main content
PMC home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1997 Sep-Dec;70(5-6):541–548.

Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling.

C B Srikant 1
PMCID: PMC2589268  PMID: 9825481

Full text

PDF
546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baunoch D. A., Xu M., Tewari A., Christman J. K., Lane M. A. In situ dephosphorylation of p53 protein by calf intestinal alkaline phosphatase treatment. Oncogene. 1992 Nov;7(11):2351–2353. [PubMed] [Google Scholar]
  2. Bruno J. F., Xu Y., Berelowitz M. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells. Biochem Biophys Res Commun. 1994 Aug 15;202(3):1738–1743. doi: 10.1006/bbrc.1994.2136. [DOI] [PubMed] [Google Scholar]
  3. Candi E., Melino G., De Laurenzi V., Piacentini M., Guerrieri P., Spinedi A., Knight R. A. Tamoxifen and somatostatin affect tumours by inducing apoptosis. Cancer Lett. 1995 Sep 4;96(1):141–145. doi: 10.1016/0304-3835(95)03924-l. [DOI] [PubMed] [Google Scholar]
  4. Canman C. E., Gilmer T. M., Coutts S. B., Kastan M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 1995 Mar 1;9(5):600–611. doi: 10.1101/gad.9.5.600. [DOI] [PubMed] [Google Scholar]
  5. Canobbio L., Cannata D., Miglietta L., Boccardo F. Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels. Anticancer Res. 1995 Nov-Dec;15(6B):2687–2690. [PubMed] [Google Scholar]
  6. Cheung N. W., Boyages S. C. Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology. 1995 Oct;136(10):4174–4181. doi: 10.1210/endo.136.10.7664634. [DOI] [PubMed] [Google Scholar]
  7. Hermeking H., Funk J. O., Reichert M., Ellwart J. W., Eick D. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene. 1995 Oct 5;11(7):1409–1415. [PubMed] [Google Scholar]
  8. Hierowski M. T., Liebow C., du Sapin K., Schally A. V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett. 1985 Jan 7;179(2):252–256. doi: 10.1016/0014-5793(85)80529-9. [DOI] [PubMed] [Google Scholar]
  9. Hofland L. J., van Koetsveld P. M., Waaijers M., Zuyderwijk J., Breeman W. A., Lamberts S. W. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology. 1995 Sep;136(9):3698–3706. doi: 10.1210/endo.136.9.7649075. [DOI] [PubMed] [Google Scholar]
  10. Hukovic N., Panetta R., Kumar U., Patel Y. C. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology. 1996 Sep;137(9):4046–4049. doi: 10.1210/endo.137.9.8756582. [DOI] [PubMed] [Google Scholar]
  11. Huynh H., Pollak M. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem Biophys Res Commun. 1994 Aug 30;203(1):253–259. doi: 10.1006/bbrc.1994.2175. [DOI] [PubMed] [Google Scholar]
  12. Kastan M. B., Zhan Q., el-Deiry W. S., Carrier F., Jacks T., Walsh W. V., Plunkett B. S., Vogelstein B., Fornace A. J., Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992 Nov 13;71(4):587–597. doi: 10.1016/0092-8674(92)90593-2. [DOI] [PubMed] [Google Scholar]
  13. Krenning E. P., Bakker W. H., Kooij P. P., Breeman W. A., Oei H. Y., de Jong M., Reubi J. C., Visser T. J., Bruns C., Kwekkeboom D. J. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med. 1992 May;33(5):652–658. [PubMed] [Google Scholar]
  14. Pagliacci M. C., Tognellini R., Grignani F., Nicoletti I. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology. 1991 Nov;129(5):2555–2562. doi: 10.1210/endo-129-5-2555. [DOI] [PubMed] [Google Scholar]
  15. Pan M. G., Florio T., Stork P. J. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science. 1992 May 22;256(5060):1215–1217. doi: 10.1126/science.256.5060.1215. [DOI] [PubMed] [Google Scholar]
  16. Patel Y. C., Greenwood M. T., Panetta R., Demchyshyn L., Niznik H., Srikant C. B. The somatostatin receptor family. Life Sci. 1995;57(13):1249–1265. doi: 10.1016/0024-3205(95)02082-t. [DOI] [PubMed] [Google Scholar]
  17. Patel Y. C., Greenwood M., Panetta R., Hukovic N., Grigorakis S., Robertson L. A., Srikant C. B. Molecular biology of somatostatin receptor subtypes. Metabolism. 1996 Aug;45(8 Suppl 1):31–38. doi: 10.1016/s0026-0495(96)90076-1. [DOI] [PubMed] [Google Scholar]
  18. Patel Y. C., Panetta R., Escher E., Greenwood M., Srikant C. B. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem. 1994 Jan 14;269(2):1506–1509. [PubMed] [Google Scholar]
  19. Pearson D. A., Lister-James J., McBride W. J., Wilson D. M., Martel L. J., Civitello E. R., Taylor J. E., Moyer B. R., Dean R. T. Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies. J Med Chem. 1996 Mar 29;39(7):1361–1371. doi: 10.1021/jm950111m. [DOI] [PubMed] [Google Scholar]
  20. Reisine T., Bell G. I. Molecular biology of somatostatin receptors. Endocr Rev. 1995 Aug;16(4):427–442. doi: 10.1210/edrv-16-4-427. [DOI] [PubMed] [Google Scholar]
  21. Sakakura C., Sweeney E. A., Shirahama T., Igarashi Y., Hakomori S., Tsujimoto H., Imanishi T., Ohgaki M., Yamazaki J., Hagiwara A. Overexpression of bax enhances the radiation sensitivity in human breast cancer cells. Surg Today. 1997;27(1):90–93. doi: 10.1007/BF01366949. [DOI] [PubMed] [Google Scholar]
  22. Sharma K., Patel Y. C., Srikant C. B. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol. 1996 Dec;10(12):1688–1696. doi: 10.1210/mend.10.12.8961277. [DOI] [PubMed] [Google Scholar]
  23. Sharma K., Srikant C. B. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer. 1998 Apr 13;76(2):259–266. doi: 10.1002/(sici)1097-0215(19980413)76:2<259::aid-ijc14>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  24. Smith-Jones P. M., Stolz B., Bruns C., Albert R., Reist H. W., Fridrich R., Mäcke H. R. Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med. 1994 Feb;35(2):317–325. [PubMed] [Google Scholar]
  25. Srikant C. B. Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells. Biochem Biophys Res Commun. 1995 Apr 17;209(2):400–406. doi: 10.1006/bbrc.1995.1517. [DOI] [PubMed] [Google Scholar]
  26. Srikant C. B., Shen S. H. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells. Endocrinology. 1996 Aug;137(8):3461–3468. doi: 10.1210/endo.137.8.8754775. [DOI] [PubMed] [Google Scholar]
  27. Weckbecker G., Tolcsvai L., Stolz B., Pollak M., Bruns C. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas. Cancer Res. 1994 Dec 15;54(24):6334–6337. [PubMed] [Google Scholar]
  28. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 1995 May 5;81(3):323–330. doi: 10.1016/0092-8674(95)90385-2. [DOI] [PubMed] [Google Scholar]
  29. Xu Y., Song J., Berelowitz M., Bruno J. F. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology. 1996 Dec;137(12):5634–5640. doi: 10.1210/endo.137.12.8940394. [DOI] [PubMed] [Google Scholar]
  30. de Jong M., Breeman W. A., Bernard B. F., Rolleman E. J., Hofland L. J., Visser T. J., Setyono-Han B., Bakker W. H., van der Pluijm M. E., Krenning E. P. Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med. 1995 Jul;22(7):608–616. doi: 10.1007/BF01254561. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES